Welcome to our new website
As well as being able to load content faster than ever before, you'll now find it's much easier to find all the content you need about the Asian business world.
IHH Healthcare Bhd.
- 6.05 MYR
- -0.07
- -1.14%
Malaysia
Apr 20, 2018Ticker
KLS(5225)Prev. close
6.12Market cap (MYR)
50,426.30MMarket cap (USD)
12,938.10MShares
8,239.60M
In the news
- India's Fortis Healthcare rules out Chinese and Malaysian bids Apr 19, 2018
- Battle for Indian hospital chain intensifies with Chinese bid Apr 19, 2018
- Singapore stocks rise to two-month highs on China's surprise bank reserve ratio cut Apr 18, 2018
- Nikkei Asia300 Index rises after China's central bank cuts RRR Apr 18, 2018
- Malaysia's KLCI index rises to three-year high, led by Petronas stocks Apr 17, 2018 See more articles on IHH Healthcare Bhd.
Company Background
IHH Healthcare runs 37 private hospitals in 10 countries, including China and India. Its facilities have a total of more than 6,000 beds.
Headquartered in Malaysia, the company also sees Singapore and Turkey as its home markets. Its hospitals in these three countries attract affluent patients from across Southeast Asia and the Middle East. The group's Mount Elizabeth and Gleneagles hospitals in Singapore are considered particularly prestigious, thanks to their state-of-the-art medical equipment.
IHH is 44% owned by Khazanah Nasional, an investment arm of the Malaysian government. Khazanah in 2010 defeated a rival bid from India's Fortis Healthcare to take control of Parkway Holdings, a then-listed Singaporean company, which owned hospitals in Malaysia and Singapore. Today, Parkway is a wholly owned IHH subsidiary.
IHH is listed in both Malaysia and Singapore. The group is led by CEO Tan See Leng, who is also a doctor. Tan joined Parkway in 2004 and held various high-ranking positions before the company slid under IHH's umbrella.
Globally, IHH is the second-largest health care operator by market capitalization. Japanese trading house Mitsui & Co. is a major shareholder.
Business Summary
Financial Highlights
| Dec 2017 | MYR | USD |
| Revenue | 11,142.63M | 2,591.60M |
| Gross Profit | 2,620.19M | 609.41M |
| Operating income | 1,210.09M | 281.44M |
| Income before tax | 1,162.33M | 270.34M |
| Net income | 931.31M | 216.60M |
| EBITDA | 2,188.17M | 508.93M |
| Diluted EPS | 0.11 | 0.02 |
| Dividends Per Share | 0.03 | 0.00 |
| Total Assets | 38,924.22M | 9,618.04M |
| Total liabilities | 15,182.16M | 3,751.46M |
| Total equity | 21,890.16M | 5,408.98M |
| Operating cash flow | 1,940.31M | 451.28M |
| Currency in MYR | Currency in USD |
Historical Data
| Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | |
| Revenue | 6,756.45M | 7,344.01M | 8,455.46M | 10,021.88M | 11,142.63M |
| Gross Profit | 1,762.67M | 2,020.36M | 2,327.18M | 2,657.91M | 2,620.19M |
| Operating income | 926.70M | 1,074.16M | 1,210.55M | 1,227.74M | 1,210.09M |
| Income before tax | 879.38M | 1,211.32M | 1,203.25M | 860.94M | 1,162.33M |
| Net income | 631.15M | 754.29M | 933.90M | 612.35M | 931.31M |
| EBITDA | 1,527.56M | 1,682.34M | 1,900.05M | 2,026.87M | 2,188.17M |
| Diluted EPS | 0.07 | 0.09 | 0.11 | 0.07 | 0.11 |
| Dividends Per Share | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 |
| Total Assets | 27,261.54M | 28,680.13M | 35,517.48M | 37,200.39M | 38,924.22M |
| Total liabilities | 7,338.60M | 7,366.73M | 11,280.78M | 13,307.23M | 15,182.16M |
| Total equity | 18,075.14M | 19,451.74M | 22,155.73M | 21,985.74M | 21,890.16M |
| Operating cash flow | 1,241.46M | 1,557.92M | 1,863.97M | 1,730.45M | 1,940.31M |
| Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | |
| Revenue | 2,144.57M | 2,244.48M | 2,162.70M | 2,419.15M | 2,591.60M |
| Gross Profit | 559.49M | 617.46M | 595.23M | 641.58M | 609.41M |
| Operating income | 294.14M | 328.28M | 309.63M | 296.36M | 281.44M |
| Income before tax | 279.12M | 370.20M | 307.76M | 207.82M | 270.34M |
| Net income | 200.33M | 230.52M | 238.86M | 147.81M | 216.60M |
| EBITDA | 484.86M | 514.16M | 485.98M | 489.26M | 508.93M |
| Diluted EPS | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 |
| Dividends Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 8,322.86M | 8,202.52M | 8,272.38M | 8,292.55M | 9,618.04M |
| Total liabilities | 2,240.45M | 2,106.88M | 2,627.40M | 2,966.39M | 3,751.46M |
| Total equity | 5,518.28M | 5,563.20M | 5,160.29M | 4,900.96M | 5,408.98M |
| Operating cash flow | 394.05M | 476.13M | 476.75M | 417.70M | 451.28M |
Valuation Measures
| Dec 2017 | |
| PER | 51.81 |
| ROA | 2.44% |
| ROE | 4.24% |
| Operating margin | 10.86% |
| Profit margin | 8.35% |
Key executives
- CEO, MD & Non-Independent Executive Director: See Leng Tan
- Group Chief Financial Officer: Soon Teck Low
- Group Head-Internal Audit: Audrey Huang
- Assistant Vice President-Investor Relations: Penelope Koh
- Group Head-Human Capital Management: Juan Jim Tan
Shareholders
- Khazanah Nasional Bhd. (Investment Company) (40.6%)
- Mitsui & Co., Ltd. (18.0%)
- Employees Provident Fund (8.7%)
- Singapore Exchange Ltd. (5.1%)
- Permodalan Nasional Bhd. (3.5%)
- AYDINLAR MEHMET ALI (2.1%)
- Public Mutual Bhd. (1.8%)
- GIC Pte Ltd. (Investment Management) (1.8%)
- Kuwait Investment Authority (Investment Management) (1.7%)
- The Vanguard Group, Inc. (1.1%)
Contact Details
- Website:http://www.ihh-healthcare.com
- Address: Level 11 Block A, Pantai Hospital, Kuala Lumpur, 8 Jalan Bukit Pantai, Kuala Lumpur, 59100, Malaysia
- Phone: +60.3.2298.9898
Related Companies
- IHH Healthcare Bhd. (Singapore)
- Indah Capital Ltd.
- Shanghai Mai Kang Hospital Investment Management Co. Ltd.
- Bodrum Tedavi Hizmetleri A.S
- Integrated Healthcare Turkey Yatirimlari Ltd.
- Gleneagles Development Pte Ltd.
- Integrated Healthcare Holdings Ltd.
- Parkway Holdings Ltd.
Competitors
Copyright © 2018 FactSet Research Systems Inc. All rights reserved.
Last Updated on 20 Apr, 2018You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month
You have {{numberReadArticles}} FREE ARTICLE{{numberReadArticles-plural}} left this month
Your full access to the Nikkei Asian Review has expired
